1. Home
  2. GRFS vs RDNT Comparison

GRFS vs RDNT Comparison

Compare GRFS & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.13

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$68.30

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
RDNT
Founded
1940
1985
Country
Spain
United States
Employees
25247
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GRFS
RDNT
Price
$7.13
$68.30
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$10.15
$82.80
AVG Volume (30 Days)
657.9K
947.9K
Earning Date
07-28-2022
05-11-2026
Dividend Yield
1.80%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,616,630,000.00
Revenue This Year
$4.49
$22.78
Revenue Next Year
$6.42
$10.70
P/E Ratio
$18.67
N/A
Revenue Growth
N/A
13.05
52 Week Low
$6.96
$50.79
52 Week High
$11.14
$85.84

Technical Indicators

Market Signals
Indicator
GRFS
RDNT
Relative Strength Index (RSI) 38.73 74.35
Support Level N/A $64.71
Resistance Level $7.73 $74.55
Average True Range (ATR) 0.16 3.22
MACD -0.01 1.26
Stochastic Oscillator 25.97 93.48

Price Performance

Historical Comparison
GRFS
RDNT

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

Share on Social Networks: